# Apollo Hospitals Enterprise (NSE: APOLLOHOSP) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/APOLLOHOSP · Pivot · prices to 22 Oct 2026

Apollo Hospitals Enterprise (NSE: APOLLOHOSP) closed at ₹7,626.00 on 22 Oct 2026. With a market capitalisation of ₹1,22,065 Cr, it ranks 79th by market cap among the 3,928 NSE companies Pivot tracks (a large-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

Its return on equity was 20.5% in FY26. Its 52-week range is ₹6,696.50 (23 Jan 2026) to ₹9,070.50 (23 Sep 2026); the last close is 15.9% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹6,606 Cr (+18.1% year on year) and net profit ₹541 Cr (+34.0%), on a consolidated basis. Promoters held 28.02% of the company as of 30 Jun 2026; 2.49% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹7,626.00 |
| Market cap | ₹1,22,065 Cr |
| ROE | 20.5% (FY26) |
| ROCE | 19.6% (FY26) |
| Debt to equity | 0.6 |
| 52-week high | ₹9,070.50 (23 Sep 2026) |
| 52-week low | ₹6,696.50 (23 Jan 2026) |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹6,606 Cr | +18.1% | ₹541 Cr | +34.0% | ₹36.82 |
| Q3 FY26 | ₹6,477 Cr | +17.2% | ₹501 Cr | +34.0% | ₹34.94 |
| Q2 FY26 | ₹6,304 Cr | +12.8% | ₹488 Cr | +25.1% | ₹33.19 |
| Q1 FY26 | ₹5,842 Cr | +14.9% | ₹427 Cr | +40.6% | ₹30.10 |
| Q4 FY25 | ₹5,592 Cr | +13.1% | ₹404 Cr | +61.7% | ₹27.10 |
| Q3 FY25 | ₹5,527 Cr | +13.9% | ₹374 Cr | +47.9% | ₹25.89 |
| Q2 FY25 | ₹5,589 Cr | +15.3% | ₹390 Cr | +58.1% | ₹26.34 |
| Q1 FY25 | ₹5,086 Cr | +15.1% | ₹304 Cr | +81.5% | ₹21.23 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹21,794 Cr | ₹1,472 Cr |
| FY24 | ₹19,059 Cr | ₹917 Cr |
| FY23 | ₹16,613 Cr | ₹888 Cr |
| FY22 | ₹14,663 Cr | ₹1,101 Cr |
| FY21 | ₹10,560 Cr | ₹136 Cr |
| FY20 | ₹11,247 Cr | ₹435 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 28.02%
- Foreign institutions: 41.50%
- Domestic institutions: 23.72%
- Non-institutions: 6.54%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Torrent Pharmaceuticals](https://app.pivotnow.in/stock/TORNTPHARM) | — | ₹1,49,924 Cr | — | — |
| [Cipla](https://app.pivotnow.in/stock/CIPLA) | — | ₹1,09,204 Cr | — | — |
| [Zydus Lifesciences](https://app.pivotnow.in/stock/ZYDUSLIFE) | — | ₹1,07,747 Cr | — | — |
| [Lupin](https://app.pivotnow.in/stock/LUPIN) | — | ₹1,07,522 Cr | — | — |
| [Max Healthcare Institute](https://app.pivotnow.in/stock/MAXHEALTH) | — | ₹1,06,545 Cr | — | — |
| [Mankind Pharma](https://app.pivotnow.in/stock/MANKIND) | — | ₹99,705 Cr | — | — |

## Questions and answers

### What is the share price of Apollo Hospitals Enterprise today?

Apollo Hospitals Enterprise (NSE: APOLLOHOSP) last closed at ₹7,626.00 on 22 Oct 2026. Its 52-week high is ₹9,070.50 and its 52-week low is ₹6,696.50.

### What is the market cap of Apollo Hospitals Enterprise?

Apollo Hospitals Enterprise's market capitalisation is ₹1,22,065 Cr (₹1.22 lakh Cr) at the — close, ranking 79th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Apollo Hospitals Enterprise?

Return on equity was 20.5% in FY26 and return on capital employed was 19.6% in FY26 (consolidated figures).

### Is Apollo Hospitals Enterprise a debt-free company?

No. Apollo Hospitals Enterprise's debt-to-equity ratio was 0.6 in FY26, with total debt of ₹5,741 Cr.

### What were Apollo Hospitals Enterprise's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Apollo Hospitals Enterprise reported revenue of ₹6,606 Cr, +18.1% year on year, and net profit of ₹541 Cr, +34.0% year on year.

### What is the shareholding pattern of Apollo Hospitals Enterprise?

As of 30 Jun 2026: promoters 28.02%, foreign institutions 41.50%, domestic institutions 23.72%, non-institutions 6.54%. 2.49% of promoter shares were pledged.

### Who are Apollo Hospitals Enterprise's competitors?

The listed Pharma & Healthcare companies closest to Apollo Hospitals Enterprise by market cap are Torrent Pharmaceuticals, Cipla, Zydus Lifesciences, Lupin, Max Healthcare Institute and Mankind Pharma.

### Is Apollo Hospitals Enterprise a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Apollo Hospitals Enterprise's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on APOLLOHOSP against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.